Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Wegovy acts on the GLP-1 receptor to help control appetite, while Mounjaro targets both the GLP-1 and GIP receptors, which may enhance its effect in some patients
The combination produces additive effects through dual receptor engagement
Enhancing Satiety and Reducing Food Cravings Since semaglutide helps someone feel full for longer and decreases hunger cues, many people who take this drug report less food noise, obsessive thoughts about food, and fewer cravings for hyperpalatable food, like french fries or ice cream
Saxenda 3 mg daily for weight management): Proven efficacy with 5-8% weight reduction and cardiovascular outcome benefits in the LEADER trial Dulaglutide (Trulicity 0.75-4.5 mg weekly): Convenient once-weekly dosing with demonstrated cardiovascular benefit in the REWIND trial Tirzepatide (Mounjaro for diabetes
doi: 10.1038/s41591-018-0104-9 23 PeiselerMSchwabeRHampeJKubesPHeikenwlderMTackeF
US$ 23.83
US$ 25.78
US$ 29.91
